LHRH analogues and fibroids--potential for longer-term use.
Improved diagnosis has made drug treatment of uterine fibroids more of a reality. For long-term use, conclusions cannot yet be drawn on the merits of LHRH analogues administered alone or in sequence with other agents. However, such treatment enables preservation of reproductive function, whilst avoiding potential sequelae of surgical myomectomy.
West
C P
CP
Department of Obstetrics and Gyneacology, University of Edinburgh, UK.
Lumsden
M A
MA
Baird
D T
DT
D004359:Drug Therapy, Combination; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives*; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy*; D011372:Progestins / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy*
D011372:Progestins; D013629:Tamoxifen; D007987:Gonadotropin-Releasing Hormone